These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 6684202

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R, Guerin JJ, Davis KL.
    Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
    [Abstract] [Full Text] [Related]

  • 3. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF, Thal L, Gardner EL.
    Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
    [Abstract] [Full Text] [Related]

  • 4. The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
    Klawans HL, Carvey PM, Nelson D, Tanner CM, Goetz CG.
    Life Sci; 1986 May 12; 38(19):1707-14. PubMed ID: 3702600
    [Abstract] [Full Text] [Related]

  • 5. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.
    Mueller K.
    Pharmacol Biochem Behav; 1993 May 12; 45(1):71-6. PubMed ID: 8100075
    [Abstract] [Full Text] [Related]

  • 6. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
    Smith RC, Davis JM.
    Life Sci; 1976 Sep 01; 19(5):725-31. PubMed ID: 986527
    [No Abstract] [Full Text] [Related]

  • 7. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT, Rebec GV.
    Pharmacol Biochem Behav; 1988 Nov 01; 31(3):519-22. PubMed ID: 3251235
    [Abstract] [Full Text] [Related]

  • 8. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J, Devanand DP, Carey RJ.
    Biol Psychiatry; 1982 Nov 01; 17(11):1289-301. PubMed ID: 6891268
    [Abstract] [Full Text] [Related]

  • 9. Chronic thioridazine treatment differently affects DA receptors in striatum and in mesolimbo-cortical systems.
    Piazza PV, Calzà L, Giardino L, Amato G.
    Pharmacol Biochem Behav; 1990 Apr 01; 35(4):937-42. PubMed ID: 2345767
    [Abstract] [Full Text] [Related]

  • 10. Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: demonstration by in vivo electrochemistry.
    Lane RF, Blaha CD.
    Brain Res; 1987 Apr 07; 408(1-2):317-20. PubMed ID: 2439169
    [Abstract] [Full Text] [Related]

  • 11. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.
    Carvey PM, Nath ST, Kao LC, Zhang TJ, Lin DH, Singh R, Amdur RL, Klawans HL.
    Eur J Pharmacol; 1990 Aug 02; 184(1):43-53. PubMed ID: 2209714
    [Abstract] [Full Text] [Related]

  • 12. Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals.
    Fowler PJ, Zirkle CL, Macko E, Setler PE, Sarau HM, Misher A, Tedeschi DH.
    Arzneimittelforschung; 1977 Aug 02; 27(8):1589-95. PubMed ID: 410422
    [No Abstract] [Full Text] [Related]

  • 13. Behavioral effects of a dimethylsulfonium analog of dopamine after injection into the nucleus accumbens and the striatum.
    Boldry R, Chang Y, Miller DD, Uretsky NJ.
    Pharmacol Biochem Behav; 1986 Feb 02; 24(2):223-8. PubMed ID: 3081914
    [Abstract] [Full Text] [Related]

  • 14. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity.
    Lai H, Carino MA, Sperry R, Horita A.
    J Pharm Pharmacol; 1981 Apr 02; 33(4):252-4. PubMed ID: 6115914
    [No Abstract] [Full Text] [Related]

  • 15. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
    Carvey PM, Kao LC, Zhang TJ, Amdur RL, Lin DH, Singh R, Klawans HL.
    Pharmacol Biochem Behav; 1990 Feb 02; 35(2):291-300. PubMed ID: 2320636
    [Abstract] [Full Text] [Related]

  • 16. Thioridazine chronic administration: a behavioural and autoradiographic study.
    Calzà L, Giardino L, Piazza PV, Amato G.
    Neurosci Lett; 1990 Feb 05; 109(1-2):206-11. PubMed ID: 2314636
    [Abstract] [Full Text] [Related]

  • 17. Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency?
    Singhal RL, Rastogi RB, Lapierre YD.
    J Neural Transm; 1983 Feb 05; 56(2-3):127-38. PubMed ID: 6306165
    [Abstract] [Full Text] [Related]

  • 18. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR.
    Neuropsychobiology; 1983 Feb 05; 24(2):102-8. PubMed ID: 2151972
    [Abstract] [Full Text] [Related]

  • 19. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR, Johnson KM.
    J Pharmacol Exp Ther; 1989 Feb 05; 248(2):521-30. PubMed ID: 2918468
    [Abstract] [Full Text] [Related]

  • 20. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J.
    Pol J Pharmacol Pharm; 1973 Feb 05; 25(1):41-52. PubMed ID: 4798098
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.